Skip to main content
. 2019 Nov 29;3:20. doi: 10.1186/s41824-019-0066-2

Fig. 52.

Fig. 52

68Ga-DOTA peptide, staging of NET lung primary, comparison with FDG. Clinical history: 65 y.o. man. Staging of a lung mass with FDG PET and biopsy indicated a moderately differentiated NET (grade 2, Ki67 8%). Consequently, the patient underwent a second PET using 68Ga-DOTANOC to stage the disease more accurately. PET/CT findings: increased focal uptake in FDG PET in the right lung, without any other findings (a MIP). 68Ga-DOTANOC showed intense uptake in the lung and in the thyroid due to a known De Quervain thyroiditis (b MIP)